Description |
C-terminal binding protein 2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Antisaccade task score ( 31596458)
- Apolipoprotein B levels ( 32203549)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Blood pressure ( 21909110)
- Body mass index ( 28892062)
- Brain volume in infants (grey matter) ( 28763065)
- Cadmium levels ( 26025379)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Diastolic blood pressure ( 19430479 27841878 21909115 28739976 27618452)
- Diastolic blood pressure (cigarette smoking interaction) ( 29455858)
- Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Diverticular disease ( 30177863)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- Hypertension ( 31879980 19430479 21909115)
- LDL cholesterol levels ( 32203549)
- Mean arterial pressure ( 27618448)
- Mean arterial pressure x alcohol consumption interaction (2df test) ( 29912962)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (diuretics) ( 31015401)
- Metabolite levels (HVA/MHPG ratio) ( 23319000)
- Nicotine dependence symptom count ( 25555482)
- Obesity-related traits ( 23251661)
- Primary tooth development (number of teeth) ( 23704328)
- Primary tooth development (time to first tooth eruption) ( 23704328)
- Protein quantitative trait loci ( 18464913)
- Pulse pressure ( 30578418)
- Pulse pressure x alcohol consumption interaction (2df test) ( 29912962)
- Quantitative traits ( 19197348)
- Response to antiepileptic drugs in genetic generalized epilepsy ( 32308125)
- Schizophrenia ( 28991256 25056061 29483656 30285260 23974872)
- Small vessel stroke ( 26732560)
- Systolic blood pressure ( 28135244 19430479 27841878 21909115 28739976 27618452 30578418)
- Systolic blood pressure (cigarette smoking interaction) ( 29455858)
- Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- White matter hyperintensity volume ( 33293549)
|
Interacting Genes |
99 interacting genes:
ACTG1
AKTIP
APP
ATE1
BAZ2B
BCAS3
BCL3
C15orf39
CACNB1
CACNB2
CACNB3
CACNB4
CAPN7
CASP8AP2
CATSPER1
CBX4
CCDC120
CCNH
CCR5
CDKN2A
CEP68
CSTF2
CTBP1
CTPS2
DMRTB1
DTNB
DUSP21
DVL2
EEF1D
EGLN3
EIF4G1
ELAC2
ENKD1
EP300
FHL3
FLI1
FOXP2
FUNDC1
GLIS2
H3-4
HEMGN
HIC1
HOXA5
HOXB5
HOXC5
IKZF1
IKZF2
KCNIP3
KLF3
KLF8
KYNU
LCORL
LMO4
MDM2
MECOM
MSRB3
NEK6
NOL4
NOL4L
NRIP1
PLCB1
PNN
PPP1R15A
PROX1
PSMF1
QARS1
RAI2
RBBP8NL
RIMBP3
RNF135
RPL17
RPL7A
RPS28
RPS29
RPS4X
SDCBP
SHISA6
SOX13
SOX6
STUB1
STX11
TEAD3
TGIF1
TLE5
TRIML2
TSHZ3
UBC
UBE2I
VRTN
XRCC6
ZBP1
ZBTB42
ZEB1
ZEB2
ZFPM1
ZFPM2
ZNF512B
ZNF750
ZSCAN4
|
13 interacting genes:
C10orf67
CTBP2
GPR85
HEXIM2
MSRB2
NEBL
NRP1
PDIA3
PRKACA
PRMT5
PTER
REM1
TMEM174
|
Entrez ID |
1488 |
783 |
HPRD ID |
04016 |
02473 |
Ensembl ID |
ENSG00000175029
|
ENSG00000165995
|
Uniprot IDs |
P56545
|
A0A494C0B2
A0A494C184
Q08289
Q59H42
Q5VVH1
|
PDB IDs |
2OME
4LCJ
6WKW
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|